NCT07171658Recrutement en cours
Breast Cancer-Related Approach for Increasing Cervical Cancer Screening
Résumé
The primary objective of this clinical trial is to assess cervical cancer screening participation among under-screened women invited through organized breast cancer screening programs in Switzerland. This randomized trial will compare three arms: 1. Intervention group 1: Sensitization to Cervical Cancer (CC) screening Women will receive an awareness letter explaining the importance of cervical cancer screening, the Swiss recommendations and an invitation to schedule an appointment. 2. Intervention group 2: Home-based Human papillomavirus infection (HPV) self-sampling Women will receive a free-of-charge vaginal self-sampling kit for HPV infection 3. Observational control group Women selected in the control arm will only be recruited one year following the screening of those in the intervention arm (T0+1), as to not influence Cervical Cancer Screening (CCS) behavior during this period by being reminded of screening recommendations.
Critères d'inclusion
• Women receiving Breast Cancer Screening (BCS) invitation letters in the selected five cantons (Geneva, Bern (francophone), Jura, Neuchâtel, and Vaud) • Aged 50 to 74 years old • Not been screened for cervical cancer in the past three years • Speaking one of the 6 languages of the study (French, German, Italian, and in English, Spanish, and Portuguese)
Critères d'exclusion
• Prior cervical cancer diagnosis, • Hysterectomy • Non consent to participate to the study • Incapable of judgment or under tutelage • Pregnancy
Contacts
Les coordonnées de l'équipe de l'essai s'affichent sur demande.
Voir la fiche officielle de l'essai- Statut
- Recrutement en cours
- Phase
- Sans phase (N/A)
- Type d'étude
- Interventionnelle
- Pays
- Suisse
- Promoteur
- Jessica Di Vincenzo Sormani(Autre)
- N° de protocole
- 32HW-0_228666
- Pathologies
- Cervical Cancer Screening
- Interventions
- Comportemental
Traitements évalués
- Sensitization to Cervical Cancer (CC) screening
- Home-based HPV self-sampling
Collaborateurs
University Hospital, Geneva
Lieux · 1
- Geneva, SuisseUniversity Hospitals of GenevaRecrute dans ce centre
Au total, dans le monde, le seul centre listé au registre recrute.
Statut par centre selon le registre ClinicalTrials.gov (dernière mise à jour publiée : 22 décembre 2025).
Ce statut peut avoir changé et ne dit rien de votre éligibilité : avant toute démarche, vérifiez avec votre oncologue ou le centre.
Voir aussi
Autres versions
Ces résultats sont indicatifs et ne remplacent pas un avis médical — à discuter avec votre médecin.